ARIA Risk, APOE4 and Alzheimer’s Treatment Explained
When I was diagnosed with Alzheimer’s and learned that APOE could affect my risk of ARIA, I realized I didn't understand the difference between a gene, an allele, and a protein. This is the story of what I learned; what ARIA is; how to understand an APOE genetic blood test, what the risks are and how the risk is monitored.
How Leqembi and Kisunla Fight Alzheimer's in Different Ways
A diagnosis of Alzheimer's no longer means there are no treatment options. Two FDA-approved drugs, Leqembi and Kisunla, can slow the disease for people diagnosed early, but they work differently. Understanding how beta-amyloid changes from harmless protein fragments into toxic oligomers, protofibrils, plaques, and eventually tau tangles can help patients and families make more informed treatment decisions.